The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed with Intraductal Papilloma without Atypia or Flat Epithelial Atypia by Core Needle Biopsy

K
Kandice Ludwig, MD

Primary Investigator

Overview

The purpose of this study is to find out how often cancer is identified by excisional biopsy near an initial core biopsy where FEA or IPWA has previously been seen.

Description

The purpose of this study is to find out how often cancer is identified by excisional biopsy near an initial core biopsy where flat epithelia atypia or intraductal papilloma without atypia has previously been seen.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Adjacent Synchronous Ipsilateral Infiltrating Carcinoma,Intraductal Papilloma,flat epithelia atypia,intraductal papilloma without atypia
  • Age: Between 18 Years - 100 Years
  • Gender: Female

Inclusion Criteria
Must have an imaging abnormality that necessitated a core needle biopsy
Patients must be registered on study within 60 days after core needle biopsy
Exclusion Criteria
Personal history and/or concomitant diagnosis of invasive breast cancer or DCIS
Palpable abnormality diagnosed by core needle biopsy to be FEA or IPWA
Pathologic nipple discharge associated with IPWA
A BIRADS 5 lesion
Discordance between the initial breast imaging finding and the core biopsy pathology report
The presence of atypical ductal hyperplasia on core biopsy
Known current pregnancy
Women who are breastfeeding
Patient registered on study more than 60 days since the date of core needle biopsy


Additional Information:
Participants will not be paid for their participation.

Updated on 20 Nov 2022. Study ID: 1601641454 (TBCRC034)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center